BioCentury
ARTICLE | Emerging Company Profile

AiCure: harnessing AI to boost adherence

AiCure is applying AI to visual, vocal and behavioral patient data to optimize trial adherence

March 5, 2020 8:04 PM UTC
Updated on Mar 6, 2020 at 4:28 PM UTC

AiCure is combining a decade’s worth of research into real-world patient behavior with an artificial intelligence platform to optimize patient adherence to treatments in clinical trials.

Lack of patient compliance to long-term treatments can lead to increases in hospitalizations, unnecessary doctor visits and lost drug sales, resulting in billions of dollars of expenses for healthcare systems and biopharmas (see “Back To School: Changing The Subject”)...